Third Avenue Management started to build up the position in Veradigm in Q2 2013 and continued to invest until Q2 2014. Since then they sold 2.03 Million shares. The investor completely sold their stake between Q3 2014 and Q1 2017.
LITTLE ROCK, Ark.--(BUSINESS WIRE)--MedEvolve, a leading provider of effective intelligence technology that provides, automation, transparency and accountabi...
CHICAGO--(BUSINESS WIRE)-- #healthIT--Veradigm® (OTCMKTS: MDRX), a leading provider of healthcare data and technology solutions, announced today that Black B...
SAN FRANCISCO, Jan. 14, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges Veradigm Inc. (NASDAQ: MDRX ) investors who suffered substantial losses to submit your l...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages MDRX Investors with Substantial Losses to Contact Firm Before Jan. 22nd Deadline HAGENS BERMAN, NATIONAL ...